Revolutionizing Pathogen Detection

Using innovative molecular detection to advance the diagnosis and management of cancer

The Most Extensive Microarray Available For Pathogen Detection

PathoChip technology is a proprietary method of identifying specific microbial signatures associated with cancer. Pathochip can accurately detect pathogens that may cause or complicate a disease, impacting treatment, prognosis, and follow-up.

Potential Applications of PathoChip Include:

ENHANCE

ASSESS

SELECT

MONITOR

About Us

ExcaliVir, a molecular diagnostics company, was formed in 2012 by Dr. Erle Robertson and Dr. James Alwine, researchers from the University of Pennsylvania, Perelman School of Medicine to transform pathogen detection by combining next generation microarray and sequencing. Their passion for research on the relationship between the microbiome and human cancer has led to the development of a unique technology for rapid identification of all known infectious agents associated with human disease.